

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.05675633 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.05675633 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.05675633 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.05675633 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.05675633 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.05675633 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.98167910 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.48282630 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.29291107 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24832494 |
| 11 | microglial cell activation (GO:0001774) | 5.16449977 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86314709 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.70284236 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.65302184 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.61249667 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.50254366 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.39526882 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.26938832 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.17435929 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.07683608 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06592943 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06592943 |
| 23 | response to peptidoglycan (GO:0032494) | 4.03848052 |
| 24 | detection of other organism (GO:0098543) | 4.00650661 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.96034405 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.94327511 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.94327511 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.88923425 |
| 29 | response to host immune response (GO:0052572) | 3.86972494 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86972494 |
| 31 | negative regulation of T cell mediated immunity (GO:0002710) | 3.85930978 |
| 32 | macrophage activation (GO:0042116) | 3.82958453 |
| 33 | negative regulation of granulocyte differentiation (GO:0030853) | 3.79992929 |
| 34 | detection of bacterium (GO:0016045) | 3.79790680 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.75687003 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.72890772 |
| 37 | respiratory burst (GO:0045730) | 3.70976089 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.70827608 |
| 39 | neutrophil activation (GO:0042119) | 3.68034158 |
| 40 | regulation of tolerance induction (GO:0002643) | 3.66647291 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.65025105 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.62896095 |
| 43 | response to host (GO:0075136) | 3.62896095 |
| 44 | response to host defenses (GO:0052200) | 3.62896095 |
| 45 | granulocyte activation (GO:0036230) | 3.61594103 |
| 46 | regulation of antigen processing and presentation (GO:0002577) | 3.61174693 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57248492 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.57034102 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.55784117 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53948363 |
| 51 | positive regulation of interferon-beta production (GO:0032728) | 3.48986626 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.46401492 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45185761 |
| 54 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.42310544 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.39719457 |
| 56 | cellular extravasation (GO:0045123) | 3.39610727 |
| 57 | I-kappaB phosphorylation (GO:0007252) | 3.38567805 |
| 58 | positive regulation of tolerance induction (GO:0002645) | 3.36760695 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34114894 |
| 60 | tolerance induction (GO:0002507) | 3.30539532 |
| 61 | T cell migration (GO:0072678) | 3.28468990 |
| 62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.28316182 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.27993189 |
| 64 | germinal center formation (GO:0002467) | 3.27084891 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.26595251 |
| 66 | positive regulation of chemokine secretion (GO:0090197) | 3.26540551 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.26093656 |
| 68 | positive regulation of type 2 immune response (GO:0002830) | 3.25965004 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.24814449 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.24814449 |
| 71 | response to type I interferon (GO:0034340) | 3.24071879 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23983714 |
| 73 | T cell selection (GO:0045058) | 3.22849706 |
| 74 | response to protozoan (GO:0001562) | 3.19975509 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 3.19328229 |
| 76 | myeloid dendritic cell differentiation (GO:0043011) | 3.19200573 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 3.16106391 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15463015 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15230827 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 3.14830311 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.14830311 |
| 82 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.14827356 |
| 83 | B cell mediated immunity (GO:0019724) | 3.14825668 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13011816 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.12654549 |
| 86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09368037 |
| 87 | positive thymic T cell selection (GO:0045059) | 3.09127652 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 3.08007894 |
| 89 | interferon-gamma production (GO:0032609) | 3.07969612 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 3.05500560 |
| 91 | myeloid leukocyte activation (GO:0002274) | 3.05476579 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.04545306 |
| 93 | response to interleukin-15 (GO:0070672) | 3.04485521 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02362619 |
| 95 | leukocyte aggregation (GO:0070486) | 3.02323338 |
| 96 | negative regulation of B cell proliferation (GO:0030889) | 3.01983495 |
| 97 | negative regulation of interleukin-6 production (GO:0032715) | 3.01222775 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01188147 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01024178 |
| 100 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00499757 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00223965 |
| 102 | T-helper 1 type immune response (GO:0042088) | 2.97372404 |
| 103 | detection of biotic stimulus (GO:0009595) | 2.96864835 |
| 104 | positive T cell selection (GO:0043368) | 2.96582275 |
| 105 | thymic T cell selection (GO:0045061) | 2.93672222 |
| 106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93457753 |
| 107 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93457753 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.93372215 |
| 109 | mature B cell differentiation (GO:0002335) | 2.90084303 |
| 110 | pinocytosis (GO:0006907) | 2.89902382 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.89539866 |
| 112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89491955 |
| 113 | dendritic cell differentiation (GO:0097028) | 2.89102003 |
| 114 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88784141 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.88292592 |
| 116 | regulation of type 2 immune response (GO:0002828) | 2.87521564 |
| 117 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86567199 |
| 118 | regulation of mast cell activation (GO:0033003) | 2.86465551 |
| 119 | regulation of interleukin-12 production (GO:0032655) | 2.86255509 |
| 120 | B cell homeostasis (GO:0001782) | 2.85364021 |
| 121 | defense response to protozoan (GO:0042832) | 2.85304639 |
| 122 | cellular response to interferon-beta (GO:0035458) | 2.84912610 |
| 123 | activated T cell proliferation (GO:0050798) | 2.84289088 |
| 124 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83011395 |
| 125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81906582 |
| 126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81690626 |
| 127 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74356222 |
| 128 | leukocyte cell-cell adhesion (GO:0007159) | 2.73010450 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.72426973 |
| 130 | negative T cell selection (GO:0043383) | 2.72289267 |
| 131 | negative regulation of interleukin-17 production (GO:0032700) | 2.71957230 |
| 132 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.71479042 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 2.70561982 |
| 134 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.68732029 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68632410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.38616921 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.04984331 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.73135812 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.46653930 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.42421183 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.09990180 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.97624702 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.75036884 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54446273 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52786017 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.23727880 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12698771 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05520004 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97537222 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.85518988 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81357524 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.70076920 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55499202 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51106729 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43014926 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37171751 |
| 22 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32779272 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32751567 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31033704 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29795372 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27102289 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26823282 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 2.16271297 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15883004 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.13639590 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12862715 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08213439 |
| 33 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.93677651 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93355493 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.90044015 |
| 36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.88473565 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87399105 |
| 38 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84954069 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82163778 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76344812 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76172462 |
| 42 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70588392 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66004572 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.62176371 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59782409 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56061388 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53226721 |
| 48 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51249011 |
| 49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48357817 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47681685 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47190836 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41674280 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36864414 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34040522 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32758214 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31077969 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29428422 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28295824 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25138464 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23695367 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22959612 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20172811 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20020985 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18680964 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.14147183 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13320299 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12823035 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09173396 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05764688 |
| 70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04837078 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04317733 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03056775 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02503209 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02331497 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02246244 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00755492 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00503377 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97950642 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97865302 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97403527 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95767709 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95500421 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91160759 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90395959 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89753712 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89647891 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86637250 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86205542 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82390471 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80434071 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75749068 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75722636 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75046614 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74860277 |
| 95 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74766549 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74378106 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74284053 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73930593 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71609460 |
| 100 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71288717 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70636140 |
| 102 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69828541 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67883111 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67789871 |
| 105 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.66037240 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65573563 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.63496157 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.60781933 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56902363 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.55831088 |
| 111 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.55666330 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53956380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.81506626 |
| 2 | MP0003303_peritoneal_inflammation | 3.49530935 |
| 3 | MP0003436_decreased_susceptibility_to | 3.40122244 |
| 4 | MP0005671_abnormal_response_to | 3.39691174 |
| 5 | MP0006082_CNS_inflammation | 3.19380601 |
| 6 | MP0005387_immune_system_phenotype | 3.13352806 |
| 7 | MP0001790_abnormal_immune_system | 3.13352806 |
| 8 | MP0000685_abnormal_immune_system | 3.12856277 |
| 9 | * MP0001800_abnormal_humoral_immune | 3.11387716 |
| 10 | * MP0005000_abnormal_immune_tolerance | 3.03929983 |
| 11 | MP0002419_abnormal_innate_immunity | 2.97915193 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.96889607 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.94025289 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.87696656 |
| 15 | MP0009785_altered_susceptibility_to | 2.84914484 |
| 16 | * MP0002723_abnormal_immune_serum | 2.72621284 |
| 17 | MP0004510_myositis | 2.71246988 |
| 18 | * MP0005025_abnormal_response_to | 2.66259434 |
| 19 | * MP0001819_abnormal_immune_cell | 2.51089493 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.50387016 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.38247093 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.28330826 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.25539336 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.02610124 |
| 25 | MP0002405_respiratory_system_inflammati | 1.99546855 |
| 26 | MP0000716_abnormal_immune_system | 1.96777394 |
| 27 | MP0002398_abnormal_bone_marrow | 1.94565320 |
| 28 | MP0003724_increased_susceptibility_to | 1.93776029 |
| 29 | MP0001853_heart_inflammation | 1.93605184 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.89602248 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.85106544 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.83212170 |
| 33 | MP0009840_abnormal_foam_cell | 1.82436042 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.81609539 |
| 35 | MP0004947_skin_inflammation | 1.81006231 |
| 36 | MP0005310_abnormal_salivary_gland | 1.77084151 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.75235161 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.62737016 |
| 39 | MP0002006_tumorigenesis | 1.62695850 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.62442813 |
| 41 | MP0005451_abnormal_body_composition | 1.61815076 |
| 42 | MP0009278_abnormal_bone_marrow | 1.59415949 |
| 43 | MP0002429_abnormal_blood_cell | 1.57856518 |
| 44 | * MP0008469_abnormal_protein_level | 1.57442970 |
| 45 | MP0002722_abnormal_immune_system | 1.56778088 |
| 46 | * MP0010155_abnormal_intestine_physiology | 1.49316772 |
| 47 | MP0001873_stomach_inflammation | 1.48130786 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.43304202 |
| 49 | MP0003448_altered_tumor_morphology | 1.39230266 |
| 50 | MP0003075_altered_response_to | 1.39024765 |
| 51 | MP0008004_abnormal_stomach_pH | 1.36075371 |
| 52 | MP0000343_altered_response_to | 1.35811019 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.35546295 |
| 54 | MP0003690_abnormal_glial_cell | 1.29196546 |
| 55 | MP0002254_reproductive_system_inflammat | 1.28621131 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.27371840 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.26993570 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.26993570 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.25601378 |
| 60 | MP0008260_abnormal_autophagy | 1.24266916 |
| 61 | MP0009764_decreased_sensitivity_to | 1.18877380 |
| 62 | MP0001851_eye_inflammation | 1.18104736 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.16277979 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.11156207 |
| 65 | MP0000604_amyloidosis | 1.10920353 |
| 66 | MP0002933_joint_inflammation | 1.08469201 |
| 67 | MP0005166_decreased_susceptibility_to | 1.07763054 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.06406874 |
| 69 | MP0000858_altered_metastatic_potential | 1.03594873 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.01946947 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.00229993 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.97217014 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.93591118 |
| 74 | MP0003828_pulmonary_edema | 0.92443871 |
| 75 | MP0003866_abnormal_defecation | 0.91568998 |
| 76 | MP0010307_abnormal_tumor_latency | 0.90502697 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.88809405 |
| 78 | MP0000249_abnormal_blood_vessel | 0.88759662 |
| 79 | MP0003045_fibrosis | 0.86398374 |
| 80 | MP0009763_increased_sensitivity_to | 0.85897210 |
| 81 | MP0003091_abnormal_cell_migration | 0.84549812 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.84044296 |
| 83 | MP0002928_abnormal_bile_duct | 0.81907740 |
| 84 | MP0002132_abnormal_respiratory_system | 0.80667601 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.80294013 |
| 86 | MP0005390_skeleton_phenotype | 0.79028312 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.78506114 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.77828774 |
| 89 | MP0004381_abnormal_hair_follicle | 0.77371424 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.73555646 |
| 91 | MP0001915_intracranial_hemorrhage | 0.71624356 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.71145788 |
| 93 | MP0004883_abnormal_blood_vessel | 0.70647498 |
| 94 | MP0006054_spinal_hemorrhage | 0.66828130 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.65455493 |
| 96 | MP0005164_abnormal_response_to | 0.64861162 |
| 97 | MP0000371_diluted_coat_color | 0.64360929 |
| 98 | MP0000490_abnormal_crypts_of | 0.63586245 |
| 99 | MP0008874_decreased_physiological_sensi | 0.62969846 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.62851910 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.61851401 |
| 102 | MP0003795_abnormal_bone_structure | 0.61801079 |
| 103 | MP0000609_abnormal_liver_physiology | 0.61638425 |
| 104 | MP0008873_increased_physiological_sensi | 0.61495633 |
| 105 | MP0005023_abnormal_wound_healing | 0.60150481 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.59882325 |
| 107 | MP0004130_abnormal_muscle_cell | 0.56449496 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.54652238 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.52103607 |
| 110 | MP0001663_abnormal_digestive_system | 0.51235915 |
| 111 | MP0001501_abnormal_sleep_pattern | 0.48801491 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.48573207 |
| 113 | MP0005535_abnormal_body_temperature | 0.48213577 |
| 114 | MP0003279_aneurysm | 0.47972940 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.45502648 |
| 116 | MP0000920_abnormal_myelination | 0.43983614 |
| 117 | MP0000598_abnormal_liver_morphology | 0.43433704 |
| 118 | MP0002009_preneoplasia | 0.43235616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.07691098 |
| 2 | * Recurrent abscess formation (HP:0002722) | 5.81982580 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.57516791 |
| 4 | * Recurrent bacterial skin infections (HP:0005406) | 5.20868356 |
| 5 | Glomerulonephritis (HP:0000099) | 4.86226193 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.52478354 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.39755983 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.39755983 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.39755983 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.21630633 |
| 11 | Myositis (HP:0100614) | 4.12306791 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.10661273 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.05853397 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.92977425 |
| 15 | Recurrent viral infections (HP:0004429) | 3.87749122 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.86354237 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.67830928 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.61759145 |
| 19 | Orchitis (HP:0100796) | 3.55276810 |
| 20 | Cellulitis (HP:0100658) | 3.51567047 |
| 21 | Encephalitis (HP:0002383) | 3.47473350 |
| 22 | * Recurrent skin infections (HP:0001581) | 3.45975040 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.44286441 |
| 24 | Vasculitis (HP:0002633) | 3.38155128 |
| 25 | Complement deficiency (HP:0004431) | 3.37724777 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.36573179 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.32902012 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.31832161 |
| 29 | Optic neuritis (HP:0100653) | 3.31832161 |
| 30 | Obstructive lung disease (HP:0006536) | 3.21450647 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21450647 |
| 32 | Gingivitis (HP:0000230) | 3.15399406 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.14673353 |
| 34 | Meningitis (HP:0001287) | 3.14122470 |
| 35 | Chronic otitis media (HP:0000389) | 3.10163754 |
| 36 | Stomatitis (HP:0010280) | 3.08816531 |
| 37 | Agammaglobulinemia (HP:0004432) | 3.07386950 |
| 38 | Disinhibition (HP:0000734) | 3.01327687 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99405325 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99405325 |
| 41 | Abnormality of complement system (HP:0005339) | 2.97718693 |
| 42 | Pustule (HP:0200039) | 2.93177443 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.89705579 |
| 44 | Increased IgM level (HP:0003496) | 2.88537971 |
| 45 | Axonal loss (HP:0003447) | 2.87307697 |
| 46 | IgM deficiency (HP:0002850) | 2.86125784 |
| 47 | Nephritis (HP:0000123) | 2.86061050 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.85570840 |
| 49 | Abnormality of T cells (HP:0002843) | 2.79533866 |
| 50 | Myocardial infarction (HP:0001658) | 2.76750757 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.73630838 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.72122060 |
| 53 | Periodontitis (HP:0000704) | 2.71945286 |
| 54 | Gangrene (HP:0100758) | 2.70106169 |
| 55 | Osteomyelitis (HP:0002754) | 2.69894915 |
| 56 | Chest pain (HP:0100749) | 2.68989945 |
| 57 | Arterial thrombosis (HP:0004420) | 2.65142591 |
| 58 | Leukocytosis (HP:0001974) | 2.62410524 |
| 59 | Chronic diarrhea (HP:0002028) | 2.59797156 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.58343502 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57580526 |
| 62 | Basal ganglia calcification (HP:0002135) | 2.57132924 |
| 63 | Pulmonary embolism (HP:0002204) | 2.56749293 |
| 64 | * Colitis (HP:0002583) | 2.55800061 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53874630 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.53874630 |
| 67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.51297291 |
| 68 | Amyloidosis (HP:0011034) | 2.51101525 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.50955908 |
| 70 | Nasal polyposis (HP:0100582) | 2.50405634 |
| 71 | * Inflammation of the large intestine (HP:0002037) | 2.50133152 |
| 72 | Anorexia (HP:0002039) | 2.49070551 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.43044244 |
| 74 | Increased serum ferritin (HP:0003281) | 2.42800919 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42737743 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42737743 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42737743 |
| 78 | Agnosia (HP:0010524) | 2.41270333 |
| 79 | Eosinophilia (HP:0001880) | 2.36449114 |
| 80 | Thrombocytosis (HP:0001894) | 2.35250676 |
| 81 | Loss of speech (HP:0002371) | 2.33512274 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.33506609 |
| 83 | Episodic fever (HP:0001954) | 2.33492822 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.33369308 |
| 85 | * Gastrointestinal inflammation (HP:0004386) | 2.32760189 |
| 86 | Joint swelling (HP:0001386) | 2.32367786 |
| 87 | Gingival bleeding (HP:0000225) | 2.32165731 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.31966971 |
| 89 | Polyneuropathy (HP:0001271) | 2.31759818 |
| 90 | Granulocytopenia (HP:0001913) | 2.29408388 |
| 91 | Increased IgE level (HP:0003212) | 2.28208409 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.28174981 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.28004356 |
| 94 | Purpura (HP:0000979) | 2.25749942 |
| 95 | Lymphopenia (HP:0001888) | 2.23434702 |
| 96 | Petechiae (HP:0000967) | 2.21021611 |
| 97 | Arterial tortuosity (HP:0005116) | 2.20765630 |
| 98 | Urticaria (HP:0001025) | 2.18675163 |
| 99 | Glomerulopathy (HP:0100820) | 2.18457880 |
| 100 | Emphysema (HP:0002097) | 2.17432290 |
| 101 | Thick nail (HP:0001805) | 2.15341466 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15026738 |
| 103 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14970528 |
| 104 | Vertigo (HP:0002321) | 2.13590215 |
| 105 | Thyroiditis (HP:0100646) | 2.12663340 |
| 106 | Abnormality of T cell number (HP:0011839) | 2.11639349 |
| 107 | Epistaxis (HP:0000421) | 2.10887810 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 2.10768662 |
| 109 | Prolonged bleeding time (HP:0003010) | 2.09919461 |
| 110 | Prostate neoplasm (HP:0100787) | 2.09798318 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.08517832 |
| 112 | T lymphocytopenia (HP:0005403) | 2.07499464 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.06275230 |
| 114 | Hemoptysis (HP:0002105) | 2.04694310 |
| 115 | Impaired platelet aggregation (HP:0003540) | 2.04056893 |
| 116 | Abnormal platelet function (HP:0011869) | 2.04056893 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 2.03822845 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 2.02639421 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02639421 |
| 120 | Recurrent sinusitis (HP:0011108) | 2.01413472 |
| 121 | Fatigue (HP:0012378) | 2.01276569 |
| 122 | Severe combined immunodeficiency (HP:0004430) | 2.00896766 |
| 123 | Acne (HP:0001061) | 2.00156147 |
| 124 | Amaurosis fugax (HP:0100576) | 2.00093964 |
| 125 | Restrictive lung disease (HP:0002091) | 1.98830271 |
| 126 | Arthralgia (HP:0002829) | 1.98661107 |
| 127 | Abnormality of T cell physiology (HP:0011840) | 1.98178382 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.97972527 |
| 129 | Mutism (HP:0002300) | 1.97400515 |
| 130 | IgG deficiency (HP:0004315) | 1.97298729 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.97082949 |
| 132 | Abnormality of the endocardium (HP:0004306) | 1.97005745 |
| 133 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96626721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.80913571 |
| 2 | TGFBR2 | 3.59390192 |
| 3 | MAP3K14 | 3.42649758 |
| 4 | BLK | 3.29849063 |
| 5 | PRPF4B | 3.24773862 |
| 6 | RIPK4 | 3.18218447 |
| 7 | IRAK4 | 2.98648599 |
| 8 | * TYK2 | 2.94557141 |
| 9 | TBK1 | 2.93731149 |
| 10 | IRAK3 | 2.82129042 |
| 11 | CSF1R | 2.78149029 |
| 12 | ERN1 | 2.30083062 |
| 13 | IKBKB | 2.24267797 |
| 14 | IKBKE | 2.23432625 |
| 15 | KIT | 2.22236570 |
| 16 | JAK3 | 2.19737752 |
| 17 | STK10 | 2.08733105 |
| 18 | TXK | 2.02956745 |
| 19 | CSK | 1.86143935 |
| 20 | ZAP70 | 1.82802020 |
| 21 | MAP3K13 | 1.81400758 |
| 22 | * JAK1 | 1.78934372 |
| 23 | SYK | 1.65162810 |
| 24 | GRK7 | 1.61158820 |
| 25 | CDK12 | 1.57642839 |
| 26 | MAPK15 | 1.57299097 |
| 27 | HCK | 1.53880581 |
| 28 | MAP3K10 | 1.49543465 |
| 29 | TNK2 | 1.49359750 |
| 30 | BTK | 1.44686533 |
| 31 | FES | 1.39042635 |
| 32 | TAOK1 | 1.33975118 |
| 33 | EPHB1 | 1.33196699 |
| 34 | CHUK | 1.32744066 |
| 35 | TAOK2 | 1.32698004 |
| 36 | LCK | 1.32609160 |
| 37 | MAP3K11 | 1.31785991 |
| 38 | SIK2 | 1.29252469 |
| 39 | MATK | 1.26411096 |
| 40 | JAK2 | 1.24761782 |
| 41 | NEK9 | 1.23838841 |
| 42 | ITK | 1.23820701 |
| 43 | LYN | 1.23761410 |
| 44 | CDC42BPA | 1.14342769 |
| 45 | CLK1 | 1.13523886 |
| 46 | CAMK1D | 1.10707820 |
| 47 | MAP3K1 | 1.07696124 |
| 48 | GRK6 | 1.06638836 |
| 49 | FGR | 1.06138574 |
| 50 | FGFR4 | 1.04675126 |
| 51 | MARK3 | 1.02271512 |
| 52 | PIM1 | 1.00892573 |
| 53 | TEC | 1.00265714 |
| 54 | TAOK3 | 0.99989152 |
| 55 | FGFR3 | 0.99474052 |
| 56 | CAMKK2 | 0.97646975 |
| 57 | RPS6KA4 | 0.97595522 |
| 58 | MAP2K3 | 0.97551677 |
| 59 | LRRK2 | 0.93922935 |
| 60 | TESK2 | 0.80812565 |
| 61 | TRIB3 | 0.75441338 |
| 62 | CDK6 | 0.72200285 |
| 63 | MARK2 | 0.72066151 |
| 64 | CAMK1G | 0.71817403 |
| 65 | PTK6 | 0.70896981 |
| 66 | MST4 | 0.70250055 |
| 67 | PAK4 | 0.68793826 |
| 68 | CAMKK1 | 0.63032487 |
| 69 | PKN2 | 0.60731916 |
| 70 | NLK | 0.60115849 |
| 71 | PIM2 | 0.58934827 |
| 72 | PDK1 | 0.58931440 |
| 73 | STK4 | 0.57786591 |
| 74 | PRKCQ | 0.56600699 |
| 75 | MAPKAPK2 | 0.56485733 |
| 76 | KSR2 | 0.56272261 |
| 77 | TYRO3 | 0.55396248 |
| 78 | EGFR | 0.55119194 |
| 79 | MAP3K5 | 0.53196582 |
| 80 | BMPR2 | 0.52980808 |
| 81 | NME2 | 0.52732772 |
| 82 | FLT3 | 0.51102814 |
| 83 | MAPK12 | 0.51003668 |
| 84 | ABL1 | 0.49753555 |
| 85 | TTN | 0.49105150 |
| 86 | IRAK1 | 0.48376396 |
| 87 | PKN1 | 0.47119164 |
| 88 | EEF2K | 0.46496991 |
| 89 | MOS | 0.45087586 |
| 90 | MAP2K6 | 0.43990905 |
| 91 | DDR2 | 0.43592052 |
| 92 | CDK9 | 0.43255145 |
| 93 | SIK3 | 0.43242262 |
| 94 | MAP3K3 | 0.43070031 |
| 95 | MAPK7 | 0.42107299 |
| 96 | DYRK1B | 0.41755087 |
| 97 | PRKCD | 0.41718484 |
| 98 | EPHA3 | 0.40664064 |
| 99 | PRKD2 | 0.40336398 |
| 100 | PIK3CG | 0.40281080 |
| 101 | SGK3 | 0.38139075 |
| 102 | RPS6KA6 | 0.37649176 |
| 103 | FYN | 0.36142005 |
| 104 | HIPK2 | 0.36055974 |
| 105 | TRPM7 | 0.35314346 |
| 106 | INSR | 0.34720426 |
| 107 | IRAK2 | 0.34405658 |
| 108 | PDPK1 | 0.33851812 |
| 109 | IGF1R | 0.33155680 |
| 110 | SCYL2 | 0.32542706 |
| 111 | SIK1 | 0.32174894 |
| 112 | EIF2AK2 | 0.31528462 |
| 113 | MAP2K2 | 0.31351189 |
| 114 | MAPK4 | 0.31281038 |
| 115 | MAP3K7 | 0.31131347 |
| 116 | MAP3K8 | 0.30333711 |
| 117 | MAPK11 | 0.29791037 |
| 118 | RIPK1 | 0.29157552 |
| 119 | YES1 | 0.27581425 |
| 120 | ADRBK2 | 0.26638019 |
| 121 | RPS6KC1 | 0.26541128 |
| 122 | RPS6KL1 | 0.26541128 |
| 123 | MELK | 0.25226324 |
| 124 | PDGFRB | 0.25128768 |
| 125 | PRKAA2 | 0.24840022 |
| 126 | CDK4 | 0.23612818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.46281930 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16816998 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.91435795 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.82319559 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55301188 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45224645 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43838464 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28585004 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.16704221 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.13222635 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.10730777 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06165201 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05447334 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.00097915 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98512621 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92867105 |
| 17 | * Tuberculosis_Homo sapiens_hsa05152 | 1.90536371 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.89825863 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85113903 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.80088356 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.78026046 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76999852 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.76647507 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71090150 |
| 25 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.69171060 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.67152360 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65351578 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.65091219 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62776533 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54691601 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46768729 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45839332 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45444357 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.44752633 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43025449 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41589281 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28007100 |
| 38 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26994643 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25268994 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24839388 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.24405916 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.22333191 |
| 43 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18686024 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17355499 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15753567 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.15439422 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.09232202 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06588694 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01531574 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00343793 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99486942 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99227805 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.95065278 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.91150973 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90264104 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88543883 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87309585 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.86382764 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83186536 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80376300 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79493539 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78277435 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75260508 |
| 64 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69714494 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66566873 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.58037542 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57315405 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.55523858 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54245147 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52785852 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51386270 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50768375 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49698580 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49296285 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48871985 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48596269 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48361387 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48308567 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47474705 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44571114 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44104259 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43982228 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42917498 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41627516 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.41425811 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38575621 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38284225 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38055311 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36533057 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35915207 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35778504 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35651509 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34911185 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31544070 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.29328240 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28270082 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27251181 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.27206539 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26524496 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26186519 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24545626 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24191655 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23713260 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.23121554 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22758845 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22413346 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22204913 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21766176 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19924214 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.19732253 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18944562 |

